샘플 요청 목록

 카트 문의
시장보고서
상품코드
1797327

세계의 이식형 펌프 시장

Implantable Pumps
발행일: | 리서치사: Market Glass, Inc. (Formerly Global Industry Analysts, Inc.) | 페이지 정보: 영문 381 Pages | 배송안내 : 1-2일 (영업일 기준)

    
    
    



※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

이식형 펌프 세계 시장은 2030년까지 247억 달러에 달할 전망

2024년에 195억 달러로 추정되는 이식형 펌프 세계 시장은 2030년에는 247억 달러에 달하고, 분석 기간인 2024-2030년 CAGR은 4.0%로 성장할 것으로 예측됩니다. 이 보고서에서 분석한 부문 중 하나인 환자 제어 진통 펌프는 CAGR 3.2%를 기록하며 분석 기간 종료시에는 86억 달러에 달할 것으로 예측됩니다. 경장 펌프 분야의 성장률은 분석 기간 동안 CAGR 4.0%로 추정됩니다.

미국 시장은 53억 달러로 추정, 중국은 CAGR 7.2%로 성장 예측

미국의 이식형 펌프 시장은 2024년에 53억 달러로 추정됩니다. 세계 2위 경제 대국인 중국은 2024년부터 2030년 분석 기간 동안 CAGR 7.2%로 성장하여 2030년까지 50억 달러의 시장 규모에 달할 것으로 예측됩니다. 기타 주목할 만한 지역별 시장으로는 일본과 캐나다가 있고, 분석 기간 동안 CAGR은 각각 1.7%와 3.1%로 예측됩니다. 유럽에서는 독일이 CAGR 2.3%로 성장할 것으로 예측됩니다.

세계의 이식형 펌프 시장 - 주요 동향과 촉진요인 정리

장기 약물전달에 이식형 펌프가 필수적인 이유는 무엇일까?

이식형 펌프는 만성질환 환자의 장기 연속 약물전달을 위한 정밀 제어 장치로 각광받고 있습니다. 이 시스템은 외과적으로 이식되어 체강 내, 복막강, 혈류 등 체내 구획에 직접 표적 용량을 투여하도록 프로그램되어 있습니다. 주로 통증관리, 경련, 화학요법, 호르몬 보충요법에 사용됩니다. 체외 펌프와 달리 이식형 시스템은 감염 위험을 줄이고, 환자의 순응도를 높이며, 전신 노출을 최소화하면서 안정적인 약물 혈장 농도를 제공합니다.

경구용 약물에 반응하지 않는 중증 만성 통증 및 경련 환자에게는 저용량으로 국소 치료가 가능한 이식형 펌프를 통한 척수강 내 약물전달이 효과적입니다. 마찬가지로, 지속적인 화학요법을 받고 있는 암 환자들은 표적화된 정맥주사를 통해 반복적인 병원 방문을 피하고 독성을 줄일 수 있습니다. 전 세계적으로 암, 신경질환, 말기 장기질환에 대한 부담이 증가함에 따라 안정적이고 환자 친화적인 약물전달 메커니즘에 대한 요구가 증가하고 있습니다.

기술이 펌프의 기능과 임상 결과를 어떻게 개선하고 있는가?

기술의 발전으로 펌프의 안전성, 프로그램성, 배터리 수명이 향상되었습니다. 최신 이식형 펌프에는 프로그래밍 가능한 투여, 재충전 가능한 저장소, 임상의가 비침습적으로 주입 매개변수를 조정할 수 있는 무선 원격 측정 등의 기능이 포함되어 있습니다. 저전력 소모 전자기기와 약품의 유량, 저수지 용량, 압력 변화를 실시간으로 모니터링하는 지능형 소프트웨어로 배터리 수명을 연장하고 있습니다. 이러한 기능은 유지보수 빈도를 줄이고 장기적인 임상 결과를 개선합니다.

펌프 구조에 사용되는 재료는 생체적합성을 높이고 감염 위험을 줄이기 위해 진화하고 있습니다. 새로운 카테터 디자인은 유체의 안정성을 향상시키고 막힘과 누출을 최소화합니다. 원격 측정을 통합한 스마트 펌프는 펌프의 성능을 원격으로 모니터링할 수 있어 임상의가 고장을 조기에 발견하고 필요에 따라 치료를 조정할 수 있도록 돕고 있습니다. 전자의무기록(EMR) 및 안전한 프로그래밍 플랫폼과의 통합을 통해 데이터 추적 및 치료 맞춤화가 더욱 효율화되고 있습니다.

수요가 증가하고 있는 분야와 주요 임상용도는?

이식형 펌프의 수요는 통증 관리, 종양학, 내분비학, 신경학 분야에서 증가하고 있습니다. 허리 수술 실패 증후군이나 암과 관련된 통증을 가진 만성 통증 환자는 이식형 펌프 사용자의 상당 부분을 차지합니다. 경련 치료, 특히 뇌성마비 및 다발성 경화증 환자의 경우, 바클로펜 척수강 내 투여 펌프가 삶의 질을 크게 개선하는 데 도움이 되고 있습니다. 암 분야에서는 소화기 및 간 악성 종양에서 복막 화학요법 및 국소 약물전달에 대한 사용이 확대되고 있습니다.

내분비학 분야에서도 시장이 확대되고 있으며, 특히 호르몬 보충이나 특정 화합물의 장기 주입이 필요한 질환에 많이 사용되고 있습니다. 소아과 영역에서는 일부 신경질환에 대한 사용이 증가하고 있으며, 이식 환자에게는 이식형 시스템을 통한 면역억제제 전달이 검토되고 있습니다. 북미와 유럽에서 가장 두드러진 성장은 확립된 상환 체계와 전문 수술 전문 지식으로 인해 북미와 유럽에서 가장 두드러진 성장을 보였으며, 아시아태평양과 라틴아메리카에서는 의료 인프라가 개선됨에 따라 채택이 점차 증가하고 있습니다.

이식형 펌프 시장의 성장 원동력은?

이식형 펌프 시장의 성장은 만성 통증 및 신경 질환의 유병률 증가, 장기간 지속되는 부위별 약물전달에 대한 수요 증가, 장치의 신뢰성 및 소형화에 대한 지속적인 개선 등 여러 가지 요인에 의해 이루어지고 있습니다. 생체적합성 재료, 배터리 시스템, 프로그래밍 가능한 소프트웨어의 발전으로 보다 안전하고 효율적인 펌프 성능이 실현되고 있습니다. 합병증 발생률 감소와 환자 순응도 향상으로 병원과 외래 의료 현장 모두에서 채택이 확대되고 있습니다.

종양센터, 신경과 클리닉, 통증관리 클리닉 등 최종 사용처가 확대됨에 따라 수작업이 증가하고, 유지보수 및 재충전 서비스에 대한 수요가 증가하고 있습니다. 원격 측정과 EMR의 호환성 통합은 환자의 장기적인 모니터링과 치료의 맞춤화를 지원합니다. 고령화, 암 발병률 증가, 최소침습적 치료 옵션에 대한 투자 증가는 시장 성장에 유리한 여건을 조성하고 있습니다. 이러한 개발로 인해 이식형 펌프는 만성질환 관리, 정밀의료, 첨단 의료 제공에 있어 필수적인 도구로 자리매김하고 있습니다.

부문

제품 유형(환자 제어 진통 펌프, 경장 펌프, 인슐린 펌프, 엘라스토머 펌프, 기타 제품 유형), 용도(종양학 용도, 소아과/신생아학 용도, 소화기학 용도, 혈액학 용도, 기타 용도), 최종 용도(병원·클리닉 최종 용도, 외래 수술 센터 최종 용도, 재택 헬스케어 최종 용도)

조사 대상 기업 사례

  • Abbott Laboratories
  • AngioDynamics
  • B. Braun Melsungen AG
  • Baxter International Inc.
  • BD(Becton, Dickinson & Co.)
  • Boston Scientific Corporation
  • CareFusion(now part of BD)
  • Cognos Therapeutics Inc.
  • Debiotech SA
  • Flowonix Medical Inc.
  • Fresenius Kabi AG
  • Hospira(subsidiary of Pfizer)
  • Insulet Corporation
  • Johnson & Johnson
  • Medtronic plc
  • MOOG Inc.
  • Smiths Medical
  • Terumo Corporation
  • tricumed Medizintechnik GmbH
  • Zealand Pharma(affiliate in pumps)

AI 통합

Global Industry Analysts는 검증된 전문가 컨텐츠와 AI 툴을 통해 시장 정보와 경쟁 정보를 혁신하고 있습니다.

Global Industry Analysts는 LLM 및 업계 고유의 SLM을 조회하는 일반적인 규범을 따르는 대신 비디오 기록, 블로그, 검색 엔진 조사, 방대한 양의 기업, 제품/서비스, 시장 데이터 등 세계 전문가로부터 수집한 컨텐츠 리포지토리를 구축했습니다.

관세 영향 계수

Global Industry Analysts는 본사 소재지, 제조거점, 수출입(완제품 및 OEM)을 기준으로 기업의 경쟁력 변화를 예측하고 있습니다. 이러한 복잡하고 다면적인 시장 역학은 매출원가(COGS) 증가, 수익성 하락, 공급망 재편 등 미시적, 거시적 시장 역학 중에서도 특히 경쟁사들에게 영향을 미칠 것으로 예상됩니다.

목차

제1장 조사 방법

제2장 주요 요약

  • 시장 개요
  • 주요 기업
  • 시장 동향과 촉진요인
  • 세계 시장 전망

제3장 시장 분석

  • 미국
  • 캐나다
  • 일본
  • 중국
  • 유럽
  • 프랑스
  • 독일
  • 이탈리아
  • 영국
  • 스페인
  • 러시아
  • 기타 유럽
  • 아시아태평양
  • 호주
  • 인도
  • 한국
  • 기타 아시아태평양
  • 라틴아메리카
  • 아르헨티나
  • 브라질
  • 멕시코
  • 기타 라틴아메리카
  • 중동
  • 이란
  • 이스라엘
  • 사우디아라비아
  • 아랍에미리트
  • 기타 중동
  • 아프리카

제4장 경쟁

KSM 25.09.03

Global Implantable Pumps Market to Reach US$24.7 Billion by 2030

The global market for Implantable Pumps estimated at US$19.5 Billion in the year 2024, is expected to reach US$24.7 Billion by 2030, growing at a CAGR of 4.0% over the analysis period 2024-2030. Patient-Controlled Analgesia Pump, one of the segments analyzed in the report, is expected to record a 3.2% CAGR and reach US$8.6 Billion by the end of the analysis period. Growth in the Enteral Pump segment is estimated at 4.0% CAGR over the analysis period.

The U.S. Market is Estimated at US$5.3 Billion While China is Forecast to Grow at 7.2% CAGR

The Implantable Pumps market in the U.S. is estimated at US$5.3 Billion in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$5.0 Billion by the year 2030 trailing a CAGR of 7.2% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 1.7% and 3.1% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 2.3% CAGR.

Global Implantable Pumps Market - Key Trends & Drivers Summarized

Why Are Implantable Pumps Becoming Integral to Long-Term Drug Delivery?

Implantable pumps are gaining prominence as precision-controlled devices for long-term, continuous drug delivery in patients with chronic conditions. These systems are surgically implanted and programmed to deliver targeted doses directly into body compartments such as the intrathecal space, peritoneal cavity, or bloodstream. They are primarily used in pain management, spasticity, chemotherapy, and hormone replacement therapy. Unlike external pumps, implantable systems reduce infection risks, improve patient compliance, and provide steady drug plasma levels with minimal systemic exposure.

Patients with severe chronic pain or spasticity who do not respond well to oral medications benefit from intrathecal drug delivery through implantable pumps, which offer localized treatment at lower doses. Similarly, cancer patients undergoing continuous chemotherapy can avoid repeated hospital visits and reduce toxicity through targeted infusion. As the global burden of cancer, neurological disorders, and end-stage organ diseases increases, the need for stable and patient-friendly drug delivery mechanisms is rising steadily.

How Is Technology Enhancing Pump Functionality and Clinical Outcomes?

Technological advancements are improving pump safety, programmability, and battery longevity. Modern implantable pumps include features such as programmable dosing, refillable reservoirs, and wireless telemetry that allow clinicians to adjust infusion parameters non-invasively. Battery life is being extended through low-power electronics and intelligent software that monitors drug flow, reservoir volume, and pressure changes in real time. These features reduce maintenance frequency and improve long-term clinical outcomes.

Materials used in pump construction are evolving to enhance biocompatibility and reduce infection risk. New catheter designs are improving fluid stability and minimizing occlusions or leakage. Smart pumps with telemetry integration are allowing remote monitoring of pump performance, helping clinicians detect malfunctions early and adjust therapy as needed. Integration with electronic medical records (EMRs) and secure programming platforms is streamlining data tracking and therapy customization.

Where Is Demand Growing, and What Are the Key Clinical Applications?

Demand for implantable pumps is growing across pain management, oncology, endocrinology, and neurology. Chronic pain patients with failed back surgery syndrome or cancer-related pain represent a significant portion of implantable pump users. In spasticity treatment, particularly for individuals with cerebral palsy or multiple sclerosis, intrathecal baclofen pumps offer substantial improvement in quality of life. Oncology use is expanding for peritoneal chemotherapy and regional drug delivery in gastrointestinal and hepatic malignancies.

The market is also expanding in endocrinology, particularly for conditions requiring hormone replacement or long-term infusion of specific compounds. Pediatric use is increasing in select neurological conditions, and transplant patients are being considered for immunosuppressive drug delivery via implantable systems. Growth is most prominent in North America and Europe due to established reimbursement frameworks and specialized surgical expertise, but adoption is gradually rising in Asia Pacific and Latin America as healthcare infrastructure improves.

What Is Driving Growth in the Implantable Pumps Market?

Growth in the implantable pumps market is driven by several factors including rising prevalence of chronic pain and neurological disorders, increased demand for long-duration, site-specific drug delivery, and continuous improvements in device reliability and miniaturization. Advancements in biocompatible materials, battery systems, and programmable software are enabling safer and more efficient pump performance. Reduced complication rates and better patient adherence are reinforcing adoption in both hospital-based and outpatient care settings.

End-use expansion across oncology centers, neurology clinics, and pain management practices is increasing procedure volumes and driving demand for maintenance and refill services. Integration of telemetry and EMR compatibility is supporting long-term patient monitoring and therapeutic customization. Aging populations, rising cancer incidence, and increased investment in minimally invasive treatment options are creating favorable conditions for market growth. These developments are positioning implantable pumps as essential tools in chronic disease management, precision medicine, and advanced care delivery.

SCOPE OF STUDY:

The report analyzes the Implantable Pumps market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Product Type (Patient-Controlled Analgesia Pump, Enteral Pump, Insulin Pump, Elastomeric Pump, Other Product Types); Application (Oncology Application, Pediatrics / Neonatology Application, Gastroenterology Application, Hematology Application, Other Applications); End-Use (Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use, Home Healthcare End-Use)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 36 Featured) -

  • Abbott Laboratories
  • AngioDynamics
  • B. Braun Melsungen AG
  • Baxter International Inc.
  • BD (Becton, Dickinson & Co.)
  • Boston Scientific Corporation
  • CareFusion (now part of BD)
  • Cognos Therapeutics Inc.
  • Debiotech SA
  • Flowonix Medical Inc.
  • Fresenius Kabi AG
  • Hospira (subsidiary of Pfizer)
  • Insulet Corporation
  • Johnson & Johnson
  • Medtronic plc
  • MOOG Inc.
  • Smiths Medical
  • Terumo Corporation
  • tricumed Medizintechnik GmbH
  • Zealand Pharma (affiliate in pumps)

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Tariff Impact on Global Supply Chain Patterns
    • Implantable Pumps - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Prevalence of Chronic Diseases Throws the Spotlight on Implantable Pumps for Targeted Drug Delivery
    • Growing Incidence of Cancer and Severe Pain Conditions Spurs Demand for Intrathecal and Chemotherapy Infusion Systems
    • Advancements in Miniaturization and Biocompatible Materials Strengthen the Business Case for Next-Gen Implantable Pumps
    • Aging Global Population and Increasing Comorbidities Expand Addressable Market for Long-Term Drug Delivery Devices
    • Patient Preference for Reduced Hospital Visits and Home-Based Therapies Drives Adoption of Implantable Pump Solutions
    • Clinical Benefits of Continuous and Programmable Infusion Accelerate Use in Pain Management and Neurological Disorders
    • Integration with Wireless Monitoring and Smart Control Systems Enhances Safety and Treatment Precision
    • Innovation in Closed-Loop and Responsive Drug Delivery Systems Boosts Demand for Intelligent Implantable Pumps
    • Increased Use in Pediatric and Rare Disease Treatment Supports Niche Application Growth
    • Surge in Research on Biodegradable and Rechargeable Implants Fuels Development of Next-Generation Devices
    • Growing Investment in Personalized and Precision Medicine Aligns with Programmable Infusion Technologies
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Implantable Pumps Market Analysis of Annual Sales in US$ Million for Years 2014 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Implantable Pumps by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Implantable Pumps by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 4: World 16-Year Perspective for Implantable Pumps by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2014, 2025 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Patient-Controlled Analgesia Pump by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Patient-Controlled Analgesia Pump by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 7: World 16-Year Perspective for Patient-Controlled Analgesia Pump by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Enteral Pump by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Enteral Pump by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 10: World 16-Year Perspective for Enteral Pump by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Insulin Pump by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Insulin Pump by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 13: World 16-Year Perspective for Insulin Pump by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Elastomeric Pump by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Elastomeric Pump by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 16: World 16-Year Perspective for Elastomeric Pump by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Other Product Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 18: World Historic Review for Other Product Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 19: World 16-Year Perspective for Other Product Types by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 21: World Historic Review for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 22: World 16-Year Perspective for Other Applications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 23: World Recent Past, Current & Future Analysis for Oncology Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 24: World Historic Review for Oncology Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 25: World 16-Year Perspective for Oncology Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 26: World Recent Past, Current & Future Analysis for Pediatrics / Neonatology Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 27: World Historic Review for Pediatrics / Neonatology Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 28: World 16-Year Perspective for Pediatrics / Neonatology Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 29: World Recent Past, Current & Future Analysis for Gastroenterology Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 30: World Historic Review for Gastroenterology Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 31: World 16-Year Perspective for Gastroenterology Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 32: World Recent Past, Current & Future Analysis for Hematology Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 33: World Historic Review for Hematology Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 34: World 16-Year Perspective for Hematology Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 35: World Recent Past, Current & Future Analysis for Hospitals & Clinics End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 36: World Historic Review for Hospitals & Clinics End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 37: World 16-Year Perspective for Hospitals & Clinics End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 38: World Recent Past, Current & Future Analysis for Ambulatory Surgery Centers End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 39: World Historic Review for Ambulatory Surgery Centers End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 40: World 16-Year Perspective for Ambulatory Surgery Centers End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 41: World Recent Past, Current & Future Analysis for Home Healthcare End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 42: World Historic Review for Home Healthcare End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 43: World 16-Year Perspective for Home Healthcare End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Implantable Pumps Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 44: USA Recent Past, Current & Future Analysis for Implantable Pumps by Product Type - Patient-Controlled Analgesia Pump, Enteral Pump, Insulin Pump, Elastomeric Pump and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 45: USA Historic Review for Implantable Pumps by Product Type - Patient-Controlled Analgesia Pump, Enteral Pump, Insulin Pump, Elastomeric Pump and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 46: USA 16-Year Perspective for Implantable Pumps by Product Type - Percentage Breakdown of Value Sales for Patient-Controlled Analgesia Pump, Enteral Pump, Insulin Pump, Elastomeric Pump and Other Product Types for the Years 2014, 2025 & 2030
    • TABLE 47: USA Recent Past, Current & Future Analysis for Implantable Pumps by Application - Other Applications, Oncology Application, Pediatrics / Neonatology Application, Gastroenterology Application and Hematology Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 48: USA Historic Review for Implantable Pumps by Application - Other Applications, Oncology Application, Pediatrics / Neonatology Application, Gastroenterology Application and Hematology Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 49: USA 16-Year Perspective for Implantable Pumps by Application - Percentage Breakdown of Value Sales for Other Applications, Oncology Application, Pediatrics / Neonatology Application, Gastroenterology Application and Hematology Application for the Years 2014, 2025 & 2030
    • TABLE 50: USA Recent Past, Current & Future Analysis for Implantable Pumps by End-Use - Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Home Healthcare End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 51: USA Historic Review for Implantable Pumps by End-Use - Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Home Healthcare End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 52: USA 16-Year Perspective for Implantable Pumps by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Home Healthcare End-Use for the Years 2014, 2025 & 2030
  • CANADA
    • TABLE 53: Canada Recent Past, Current & Future Analysis for Implantable Pumps by Product Type - Patient-Controlled Analgesia Pump, Enteral Pump, Insulin Pump, Elastomeric Pump and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 54: Canada Historic Review for Implantable Pumps by Product Type - Patient-Controlled Analgesia Pump, Enteral Pump, Insulin Pump, Elastomeric Pump and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 55: Canada 16-Year Perspective for Implantable Pumps by Product Type - Percentage Breakdown of Value Sales for Patient-Controlled Analgesia Pump, Enteral Pump, Insulin Pump, Elastomeric Pump and Other Product Types for the Years 2014, 2025 & 2030
    • TABLE 56: Canada Recent Past, Current & Future Analysis for Implantable Pumps by Application - Other Applications, Oncology Application, Pediatrics / Neonatology Application, Gastroenterology Application and Hematology Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 57: Canada Historic Review for Implantable Pumps by Application - Other Applications, Oncology Application, Pediatrics / Neonatology Application, Gastroenterology Application and Hematology Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 58: Canada 16-Year Perspective for Implantable Pumps by Application - Percentage Breakdown of Value Sales for Other Applications, Oncology Application, Pediatrics / Neonatology Application, Gastroenterology Application and Hematology Application for the Years 2014, 2025 & 2030
    • TABLE 59: Canada Recent Past, Current & Future Analysis for Implantable Pumps by End-Use - Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Home Healthcare End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 60: Canada Historic Review for Implantable Pumps by End-Use - Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Home Healthcare End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 61: Canada 16-Year Perspective for Implantable Pumps by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Home Healthcare End-Use for the Years 2014, 2025 & 2030
  • JAPAN
    • Implantable Pumps Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 62: Japan Recent Past, Current & Future Analysis for Implantable Pumps by Product Type - Patient-Controlled Analgesia Pump, Enteral Pump, Insulin Pump, Elastomeric Pump and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 63: Japan Historic Review for Implantable Pumps by Product Type - Patient-Controlled Analgesia Pump, Enteral Pump, Insulin Pump, Elastomeric Pump and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 64: Japan 16-Year Perspective for Implantable Pumps by Product Type - Percentage Breakdown of Value Sales for Patient-Controlled Analgesia Pump, Enteral Pump, Insulin Pump, Elastomeric Pump and Other Product Types for the Years 2014, 2025 & 2030
    • TABLE 65: Japan Recent Past, Current & Future Analysis for Implantable Pumps by Application - Other Applications, Oncology Application, Pediatrics / Neonatology Application, Gastroenterology Application and Hematology Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 66: Japan Historic Review for Implantable Pumps by Application - Other Applications, Oncology Application, Pediatrics / Neonatology Application, Gastroenterology Application and Hematology Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 67: Japan 16-Year Perspective for Implantable Pumps by Application - Percentage Breakdown of Value Sales for Other Applications, Oncology Application, Pediatrics / Neonatology Application, Gastroenterology Application and Hematology Application for the Years 2014, 2025 & 2030
    • TABLE 68: Japan Recent Past, Current & Future Analysis for Implantable Pumps by End-Use - Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Home Healthcare End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 69: Japan Historic Review for Implantable Pumps by End-Use - Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Home Healthcare End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 70: Japan 16-Year Perspective for Implantable Pumps by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Home Healthcare End-Use for the Years 2014, 2025 & 2030
  • CHINA
    • Implantable Pumps Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 71: China Recent Past, Current & Future Analysis for Implantable Pumps by Product Type - Patient-Controlled Analgesia Pump, Enteral Pump, Insulin Pump, Elastomeric Pump and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 72: China Historic Review for Implantable Pumps by Product Type - Patient-Controlled Analgesia Pump, Enteral Pump, Insulin Pump, Elastomeric Pump and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 73: China 16-Year Perspective for Implantable Pumps by Product Type - Percentage Breakdown of Value Sales for Patient-Controlled Analgesia Pump, Enteral Pump, Insulin Pump, Elastomeric Pump and Other Product Types for the Years 2014, 2025 & 2030
    • TABLE 74: China Recent Past, Current & Future Analysis for Implantable Pumps by Application - Other Applications, Oncology Application, Pediatrics / Neonatology Application, Gastroenterology Application and Hematology Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 75: China Historic Review for Implantable Pumps by Application - Other Applications, Oncology Application, Pediatrics / Neonatology Application, Gastroenterology Application and Hematology Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 76: China 16-Year Perspective for Implantable Pumps by Application - Percentage Breakdown of Value Sales for Other Applications, Oncology Application, Pediatrics / Neonatology Application, Gastroenterology Application and Hematology Application for the Years 2014, 2025 & 2030
    • TABLE 77: China Recent Past, Current & Future Analysis for Implantable Pumps by End-Use - Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Home Healthcare End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 78: China Historic Review for Implantable Pumps by End-Use - Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Home Healthcare End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 79: China 16-Year Perspective for Implantable Pumps by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Home Healthcare End-Use for the Years 2014, 2025 & 2030
  • EUROPE
    • Implantable Pumps Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 80: Europe Recent Past, Current & Future Analysis for Implantable Pumps by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 81: Europe Historic Review for Implantable Pumps by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 82: Europe 16-Year Perspective for Implantable Pumps by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2014, 2025 & 2030
    • TABLE 83: Europe Recent Past, Current & Future Analysis for Implantable Pumps by Product Type - Patient-Controlled Analgesia Pump, Enteral Pump, Insulin Pump, Elastomeric Pump and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 84: Europe Historic Review for Implantable Pumps by Product Type - Patient-Controlled Analgesia Pump, Enteral Pump, Insulin Pump, Elastomeric Pump and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 85: Europe 16-Year Perspective for Implantable Pumps by Product Type - Percentage Breakdown of Value Sales for Patient-Controlled Analgesia Pump, Enteral Pump, Insulin Pump, Elastomeric Pump and Other Product Types for the Years 2014, 2025 & 2030
    • TABLE 86: Europe Recent Past, Current & Future Analysis for Implantable Pumps by Application - Other Applications, Oncology Application, Pediatrics / Neonatology Application, Gastroenterology Application and Hematology Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 87: Europe Historic Review for Implantable Pumps by Application - Other Applications, Oncology Application, Pediatrics / Neonatology Application, Gastroenterology Application and Hematology Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 88: Europe 16-Year Perspective for Implantable Pumps by Application - Percentage Breakdown of Value Sales for Other Applications, Oncology Application, Pediatrics / Neonatology Application, Gastroenterology Application and Hematology Application for the Years 2014, 2025 & 2030
    • TABLE 89: Europe Recent Past, Current & Future Analysis for Implantable Pumps by End-Use - Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Home Healthcare End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 90: Europe Historic Review for Implantable Pumps by End-Use - Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Home Healthcare End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 91: Europe 16-Year Perspective for Implantable Pumps by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Home Healthcare End-Use for the Years 2014, 2025 & 2030
  • FRANCE
    • Implantable Pumps Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 92: France Recent Past, Current & Future Analysis for Implantable Pumps by Product Type - Patient-Controlled Analgesia Pump, Enteral Pump, Insulin Pump, Elastomeric Pump and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 93: France Historic Review for Implantable Pumps by Product Type - Patient-Controlled Analgesia Pump, Enteral Pump, Insulin Pump, Elastomeric Pump and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 94: France 16-Year Perspective for Implantable Pumps by Product Type - Percentage Breakdown of Value Sales for Patient-Controlled Analgesia Pump, Enteral Pump, Insulin Pump, Elastomeric Pump and Other Product Types for the Years 2014, 2025 & 2030
    • TABLE 95: France Recent Past, Current & Future Analysis for Implantable Pumps by Application - Other Applications, Oncology Application, Pediatrics / Neonatology Application, Gastroenterology Application and Hematology Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 96: France Historic Review for Implantable Pumps by Application - Other Applications, Oncology Application, Pediatrics / Neonatology Application, Gastroenterology Application and Hematology Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 97: France 16-Year Perspective for Implantable Pumps by Application - Percentage Breakdown of Value Sales for Other Applications, Oncology Application, Pediatrics / Neonatology Application, Gastroenterology Application and Hematology Application for the Years 2014, 2025 & 2030
    • TABLE 98: France Recent Past, Current & Future Analysis for Implantable Pumps by End-Use - Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Home Healthcare End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 99: France Historic Review for Implantable Pumps by End-Use - Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Home Healthcare End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 100: France 16-Year Perspective for Implantable Pumps by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Home Healthcare End-Use for the Years 2014, 2025 & 2030
  • GERMANY
    • Implantable Pumps Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 101: Germany Recent Past, Current & Future Analysis for Implantable Pumps by Product Type - Patient-Controlled Analgesia Pump, Enteral Pump, Insulin Pump, Elastomeric Pump and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 102: Germany Historic Review for Implantable Pumps by Product Type - Patient-Controlled Analgesia Pump, Enteral Pump, Insulin Pump, Elastomeric Pump and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 103: Germany 16-Year Perspective for Implantable Pumps by Product Type - Percentage Breakdown of Value Sales for Patient-Controlled Analgesia Pump, Enteral Pump, Insulin Pump, Elastomeric Pump and Other Product Types for the Years 2014, 2025 & 2030
    • TABLE 104: Germany Recent Past, Current & Future Analysis for Implantable Pumps by Application - Other Applications, Oncology Application, Pediatrics / Neonatology Application, Gastroenterology Application and Hematology Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 105: Germany Historic Review for Implantable Pumps by Application - Other Applications, Oncology Application, Pediatrics / Neonatology Application, Gastroenterology Application and Hematology Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 106: Germany 16-Year Perspective for Implantable Pumps by Application - Percentage Breakdown of Value Sales for Other Applications, Oncology Application, Pediatrics / Neonatology Application, Gastroenterology Application and Hematology Application for the Years 2014, 2025 & 2030
    • TABLE 107: Germany Recent Past, Current & Future Analysis for Implantable Pumps by End-Use - Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Home Healthcare End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 108: Germany Historic Review for Implantable Pumps by End-Use - Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Home Healthcare End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 109: Germany 16-Year Perspective for Implantable Pumps by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Home Healthcare End-Use for the Years 2014, 2025 & 2030
  • ITALY
    • TABLE 110: Italy Recent Past, Current & Future Analysis for Implantable Pumps by Product Type - Patient-Controlled Analgesia Pump, Enteral Pump, Insulin Pump, Elastomeric Pump and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 111: Italy Historic Review for Implantable Pumps by Product Type - Patient-Controlled Analgesia Pump, Enteral Pump, Insulin Pump, Elastomeric Pump and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 112: Italy 16-Year Perspective for Implantable Pumps by Product Type - Percentage Breakdown of Value Sales for Patient-Controlled Analgesia Pump, Enteral Pump, Insulin Pump, Elastomeric Pump and Other Product Types for the Years 2014, 2025 & 2030
    • TABLE 113: Italy Recent Past, Current & Future Analysis for Implantable Pumps by Application - Other Applications, Oncology Application, Pediatrics / Neonatology Application, Gastroenterology Application and Hematology Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 114: Italy Historic Review for Implantable Pumps by Application - Other Applications, Oncology Application, Pediatrics / Neonatology Application, Gastroenterology Application and Hematology Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 115: Italy 16-Year Perspective for Implantable Pumps by Application - Percentage Breakdown of Value Sales for Other Applications, Oncology Application, Pediatrics / Neonatology Application, Gastroenterology Application and Hematology Application for the Years 2014, 2025 & 2030
    • TABLE 116: Italy Recent Past, Current & Future Analysis for Implantable Pumps by End-Use - Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Home Healthcare End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 117: Italy Historic Review for Implantable Pumps by End-Use - Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Home Healthcare End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 118: Italy 16-Year Perspective for Implantable Pumps by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Home Healthcare End-Use for the Years 2014, 2025 & 2030
  • UNITED KINGDOM
    • Implantable Pumps Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 119: UK Recent Past, Current & Future Analysis for Implantable Pumps by Product Type - Patient-Controlled Analgesia Pump, Enteral Pump, Insulin Pump, Elastomeric Pump and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 120: UK Historic Review for Implantable Pumps by Product Type - Patient-Controlled Analgesia Pump, Enteral Pump, Insulin Pump, Elastomeric Pump and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 121: UK 16-Year Perspective for Implantable Pumps by Product Type - Percentage Breakdown of Value Sales for Patient-Controlled Analgesia Pump, Enteral Pump, Insulin Pump, Elastomeric Pump and Other Product Types for the Years 2014, 2025 & 2030
    • TABLE 122: UK Recent Past, Current & Future Analysis for Implantable Pumps by Application - Other Applications, Oncology Application, Pediatrics / Neonatology Application, Gastroenterology Application and Hematology Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 123: UK Historic Review for Implantable Pumps by Application - Other Applications, Oncology Application, Pediatrics / Neonatology Application, Gastroenterology Application and Hematology Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 124: UK 16-Year Perspective for Implantable Pumps by Application - Percentage Breakdown of Value Sales for Other Applications, Oncology Application, Pediatrics / Neonatology Application, Gastroenterology Application and Hematology Application for the Years 2014, 2025 & 2030
    • TABLE 125: UK Recent Past, Current & Future Analysis for Implantable Pumps by End-Use - Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Home Healthcare End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 126: UK Historic Review for Implantable Pumps by End-Use - Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Home Healthcare End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 127: UK 16-Year Perspective for Implantable Pumps by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Home Healthcare End-Use for the Years 2014, 2025 & 2030
  • SPAIN
    • TABLE 128: Spain Recent Past, Current & Future Analysis for Implantable Pumps by Product Type - Patient-Controlled Analgesia Pump, Enteral Pump, Insulin Pump, Elastomeric Pump and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 129: Spain Historic Review for Implantable Pumps by Product Type - Patient-Controlled Analgesia Pump, Enteral Pump, Insulin Pump, Elastomeric Pump and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 130: Spain 16-Year Perspective for Implantable Pumps by Product Type - Percentage Breakdown of Value Sales for Patient-Controlled Analgesia Pump, Enteral Pump, Insulin Pump, Elastomeric Pump and Other Product Types for the Years 2014, 2025 & 2030
    • TABLE 131: Spain Recent Past, Current & Future Analysis for Implantable Pumps by Application - Other Applications, Oncology Application, Pediatrics / Neonatology Application, Gastroenterology Application and Hematology Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 132: Spain Historic Review for Implantable Pumps by Application - Other Applications, Oncology Application, Pediatrics / Neonatology Application, Gastroenterology Application and Hematology Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 133: Spain 16-Year Perspective for Implantable Pumps by Application - Percentage Breakdown of Value Sales for Other Applications, Oncology Application, Pediatrics / Neonatology Application, Gastroenterology Application and Hematology Application for the Years 2014, 2025 & 2030
    • TABLE 134: Spain Recent Past, Current & Future Analysis for Implantable Pumps by End-Use - Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Home Healthcare End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 135: Spain Historic Review for Implantable Pumps by End-Use - Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Home Healthcare End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 136: Spain 16-Year Perspective for Implantable Pumps by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Home Healthcare End-Use for the Years 2014, 2025 & 2030
  • RUSSIA
    • TABLE 137: Russia Recent Past, Current & Future Analysis for Implantable Pumps by Product Type - Patient-Controlled Analgesia Pump, Enteral Pump, Insulin Pump, Elastomeric Pump and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 138: Russia Historic Review for Implantable Pumps by Product Type - Patient-Controlled Analgesia Pump, Enteral Pump, Insulin Pump, Elastomeric Pump and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 139: Russia 16-Year Perspective for Implantable Pumps by Product Type - Percentage Breakdown of Value Sales for Patient-Controlled Analgesia Pump, Enteral Pump, Insulin Pump, Elastomeric Pump and Other Product Types for the Years 2014, 2025 & 2030
    • TABLE 140: Russia Recent Past, Current & Future Analysis for Implantable Pumps by Application - Other Applications, Oncology Application, Pediatrics / Neonatology Application, Gastroenterology Application and Hematology Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 141: Russia Historic Review for Implantable Pumps by Application - Other Applications, Oncology Application, Pediatrics / Neonatology Application, Gastroenterology Application and Hematology Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 142: Russia 16-Year Perspective for Implantable Pumps by Application - Percentage Breakdown of Value Sales for Other Applications, Oncology Application, Pediatrics / Neonatology Application, Gastroenterology Application and Hematology Application for the Years 2014, 2025 & 2030
    • TABLE 143: Russia Recent Past, Current & Future Analysis for Implantable Pumps by End-Use - Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Home Healthcare End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 144: Russia Historic Review for Implantable Pumps by End-Use - Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Home Healthcare End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 145: Russia 16-Year Perspective for Implantable Pumps by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Home Healthcare End-Use for the Years 2014, 2025 & 2030
  • REST OF EUROPE
    • TABLE 146: Rest of Europe Recent Past, Current & Future Analysis for Implantable Pumps by Product Type - Patient-Controlled Analgesia Pump, Enteral Pump, Insulin Pump, Elastomeric Pump and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 147: Rest of Europe Historic Review for Implantable Pumps by Product Type - Patient-Controlled Analgesia Pump, Enteral Pump, Insulin Pump, Elastomeric Pump and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 148: Rest of Europe 16-Year Perspective for Implantable Pumps by Product Type - Percentage Breakdown of Value Sales for Patient-Controlled Analgesia Pump, Enteral Pump, Insulin Pump, Elastomeric Pump and Other Product Types for the Years 2014, 2025 & 2030
    • TABLE 149: Rest of Europe Recent Past, Current & Future Analysis for Implantable Pumps by Application - Other Applications, Oncology Application, Pediatrics / Neonatology Application, Gastroenterology Application and Hematology Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 150: Rest of Europe Historic Review for Implantable Pumps by Application - Other Applications, Oncology Application, Pediatrics / Neonatology Application, Gastroenterology Application and Hematology Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 151: Rest of Europe 16-Year Perspective for Implantable Pumps by Application - Percentage Breakdown of Value Sales for Other Applications, Oncology Application, Pediatrics / Neonatology Application, Gastroenterology Application and Hematology Application for the Years 2014, 2025 & 2030
    • TABLE 152: Rest of Europe Recent Past, Current & Future Analysis for Implantable Pumps by End-Use - Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Home Healthcare End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 153: Rest of Europe Historic Review for Implantable Pumps by End-Use - Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Home Healthcare End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 154: Rest of Europe 16-Year Perspective for Implantable Pumps by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Home Healthcare End-Use for the Years 2014, 2025 & 2030
  • ASIA-PACIFIC
    • Implantable Pumps Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 155: Asia-Pacific Recent Past, Current & Future Analysis for Implantable Pumps by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 156: Asia-Pacific Historic Review for Implantable Pumps by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 157: Asia-Pacific 16-Year Perspective for Implantable Pumps by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2014, 2025 & 2030
    • TABLE 158: Asia-Pacific Recent Past, Current & Future Analysis for Implantable Pumps by Product Type - Patient-Controlled Analgesia Pump, Enteral Pump, Insulin Pump, Elastomeric Pump and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 159: Asia-Pacific Historic Review for Implantable Pumps by Product Type - Patient-Controlled Analgesia Pump, Enteral Pump, Insulin Pump, Elastomeric Pump and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 160: Asia-Pacific 16-Year Perspective for Implantable Pumps by Product Type - Percentage Breakdown of Value Sales for Patient-Controlled Analgesia Pump, Enteral Pump, Insulin Pump, Elastomeric Pump and Other Product Types for the Years 2014, 2025 & 2030
    • TABLE 161: Asia-Pacific Recent Past, Current & Future Analysis for Implantable Pumps by Application - Other Applications, Oncology Application, Pediatrics / Neonatology Application, Gastroenterology Application and Hematology Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 162: Asia-Pacific Historic Review for Implantable Pumps by Application - Other Applications, Oncology Application, Pediatrics / Neonatology Application, Gastroenterology Application and Hematology Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 163: Asia-Pacific 16-Year Perspective for Implantable Pumps by Application - Percentage Breakdown of Value Sales for Other Applications, Oncology Application, Pediatrics / Neonatology Application, Gastroenterology Application and Hematology Application for the Years 2014, 2025 & 2030
    • TABLE 164: Asia-Pacific Recent Past, Current & Future Analysis for Implantable Pumps by End-Use - Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Home Healthcare End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 165: Asia-Pacific Historic Review for Implantable Pumps by End-Use - Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Home Healthcare End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 166: Asia-Pacific 16-Year Perspective for Implantable Pumps by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Home Healthcare End-Use for the Years 2014, 2025 & 2030
  • AUSTRALIA
    • Implantable Pumps Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
    • TABLE 167: Australia Recent Past, Current & Future Analysis for Implantable Pumps by Product Type - Patient-Controlled Analgesia Pump, Enteral Pump, Insulin Pump, Elastomeric Pump and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 168: Australia Historic Review for Implantable Pumps by Product Type - Patient-Controlled Analgesia Pump, Enteral Pump, Insulin Pump, Elastomeric Pump and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 169: Australia 16-Year Perspective for Implantable Pumps by Product Type - Percentage Breakdown of Value Sales for Patient-Controlled Analgesia Pump, Enteral Pump, Insulin Pump, Elastomeric Pump and Other Product Types for the Years 2014, 2025 & 2030
    • TABLE 170: Australia Recent Past, Current & Future Analysis for Implantable Pumps by Application - Other Applications, Oncology Application, Pediatrics / Neonatology Application, Gastroenterology Application and Hematology Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 171: Australia Historic Review for Implantable Pumps by Application - Other Applications, Oncology Application, Pediatrics / Neonatology Application, Gastroenterology Application and Hematology Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 172: Australia 16-Year Perspective for Implantable Pumps by Application - Percentage Breakdown of Value Sales for Other Applications, Oncology Application, Pediatrics / Neonatology Application, Gastroenterology Application and Hematology Application for the Years 2014, 2025 & 2030
    • TABLE 173: Australia Recent Past, Current & Future Analysis for Implantable Pumps by End-Use - Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Home Healthcare End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 174: Australia Historic Review for Implantable Pumps by End-Use - Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Home Healthcare End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 175: Australia 16-Year Perspective for Implantable Pumps by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Home Healthcare End-Use for the Years 2014, 2025 & 2030
  • INDIA
    • Implantable Pumps Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
    • TABLE 176: India Recent Past, Current & Future Analysis for Implantable Pumps by Product Type - Patient-Controlled Analgesia Pump, Enteral Pump, Insulin Pump, Elastomeric Pump and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 177: India Historic Review for Implantable Pumps by Product Type - Patient-Controlled Analgesia Pump, Enteral Pump, Insulin Pump, Elastomeric Pump and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 178: India 16-Year Perspective for Implantable Pumps by Product Type - Percentage Breakdown of Value Sales for Patient-Controlled Analgesia Pump, Enteral Pump, Insulin Pump, Elastomeric Pump and Other Product Types for the Years 2014, 2025 & 2030
    • TABLE 179: India Recent Past, Current & Future Analysis for Implantable Pumps by Application - Other Applications, Oncology Application, Pediatrics / Neonatology Application, Gastroenterology Application and Hematology Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 180: India Historic Review for Implantable Pumps by Application - Other Applications, Oncology Application, Pediatrics / Neonatology Application, Gastroenterology Application and Hematology Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 181: India 16-Year Perspective for Implantable Pumps by Application - Percentage Breakdown of Value Sales for Other Applications, Oncology Application, Pediatrics / Neonatology Application, Gastroenterology Application and Hematology Application for the Years 2014, 2025 & 2030
    • TABLE 182: India Recent Past, Current & Future Analysis for Implantable Pumps by End-Use - Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Home Healthcare End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 183: India Historic Review for Implantable Pumps by End-Use - Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Home Healthcare End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 184: India 16-Year Perspective for Implantable Pumps by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Home Healthcare End-Use for the Years 2014, 2025 & 2030
  • SOUTH KOREA
    • TABLE 185: South Korea Recent Past, Current & Future Analysis for Implantable Pumps by Product Type - Patient-Controlled Analgesia Pump, Enteral Pump, Insulin Pump, Elastomeric Pump and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 186: South Korea Historic Review for Implantable Pumps by Product Type - Patient-Controlled Analgesia Pump, Enteral Pump, Insulin Pump, Elastomeric Pump and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 187: South Korea 16-Year Perspective for Implantable Pumps by Product Type - Percentage Breakdown of Value Sales for Patient-Controlled Analgesia Pump, Enteral Pump, Insulin Pump, Elastomeric Pump and Other Product Types for the Years 2014, 2025 & 2030
    • TABLE 188: South Korea Recent Past, Current & Future Analysis for Implantable Pumps by Application - Other Applications, Oncology Application, Pediatrics / Neonatology Application, Gastroenterology Application and Hematology Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 189: South Korea Historic Review for Implantable Pumps by Application - Other Applications, Oncology Application, Pediatrics / Neonatology Application, Gastroenterology Application and Hematology Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 190: South Korea 16-Year Perspective for Implantable Pumps by Application - Percentage Breakdown of Value Sales for Other Applications, Oncology Application, Pediatrics / Neonatology Application, Gastroenterology Application and Hematology Application for the Years 2014, 2025 & 2030
    • TABLE 191: South Korea Recent Past, Current & Future Analysis for Implantable Pumps by End-Use - Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Home Healthcare End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 192: South Korea Historic Review for Implantable Pumps by End-Use - Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Home Healthcare End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 193: South Korea 16-Year Perspective for Implantable Pumps by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Home Healthcare End-Use for the Years 2014, 2025 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 194: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Implantable Pumps by Product Type - Patient-Controlled Analgesia Pump, Enteral Pump, Insulin Pump, Elastomeric Pump and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 195: Rest of Asia-Pacific Historic Review for Implantable Pumps by Product Type - Patient-Controlled Analgesia Pump, Enteral Pump, Insulin Pump, Elastomeric Pump and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 196: Rest of Asia-Pacific 16-Year Perspective for Implantable Pumps by Product Type - Percentage Breakdown of Value Sales for Patient-Controlled Analgesia Pump, Enteral Pump, Insulin Pump, Elastomeric Pump and Other Product Types for the Years 2014, 2025 & 2030
    • TABLE 197: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Implantable Pumps by Application - Other Applications, Oncology Application, Pediatrics / Neonatology Application, Gastroenterology Application and Hematology Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 198: Rest of Asia-Pacific Historic Review for Implantable Pumps by Application - Other Applications, Oncology Application, Pediatrics / Neonatology Application, Gastroenterology Application and Hematology Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 199: Rest of Asia-Pacific 16-Year Perspective for Implantable Pumps by Application - Percentage Breakdown of Value Sales for Other Applications, Oncology Application, Pediatrics / Neonatology Application, Gastroenterology Application and Hematology Application for the Years 2014, 2025 & 2030
    • TABLE 200: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Implantable Pumps by End-Use - Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Home Healthcare End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 201: Rest of Asia-Pacific Historic Review for Implantable Pumps by End-Use - Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Home Healthcare End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 202: Rest of Asia-Pacific 16-Year Perspective for Implantable Pumps by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Home Healthcare End-Use for the Years 2014, 2025 & 2030
  • LATIN AMERICA
    • Implantable Pumps Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
    • TABLE 203: Latin America Recent Past, Current & Future Analysis for Implantable Pumps by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 204: Latin America Historic Review for Implantable Pumps by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 205: Latin America 16-Year Perspective for Implantable Pumps by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2014, 2025 & 2030
    • TABLE 206: Latin America Recent Past, Current & Future Analysis for Implantable Pumps by Product Type - Patient-Controlled Analgesia Pump, Enteral Pump, Insulin Pump, Elastomeric Pump and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 207: Latin America Historic Review for Implantable Pumps by Product Type - Patient-Controlled Analgesia Pump, Enteral Pump, Insulin Pump, Elastomeric Pump and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 208: Latin America 16-Year Perspective for Implantable Pumps by Product Type - Percentage Breakdown of Value Sales for Patient-Controlled Analgesia Pump, Enteral Pump, Insulin Pump, Elastomeric Pump and Other Product Types for the Years 2014, 2025 & 2030
    • TABLE 209: Latin America Recent Past, Current & Future Analysis for Implantable Pumps by Application - Other Applications, Oncology Application, Pediatrics / Neonatology Application, Gastroenterology Application and Hematology Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 210: Latin America Historic Review for Implantable Pumps by Application - Other Applications, Oncology Application, Pediatrics / Neonatology Application, Gastroenterology Application and Hematology Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 211: Latin America 16-Year Perspective for Implantable Pumps by Application - Percentage Breakdown of Value Sales for Other Applications, Oncology Application, Pediatrics / Neonatology Application, Gastroenterology Application and Hematology Application for the Years 2014, 2025 & 2030
    • TABLE 212: Latin America Recent Past, Current & Future Analysis for Implantable Pumps by End-Use - Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Home Healthcare End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 213: Latin America Historic Review for Implantable Pumps by End-Use - Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Home Healthcare End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 214: Latin America 16-Year Perspective for Implantable Pumps by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Home Healthcare End-Use for the Years 2014, 2025 & 2030
  • ARGENTINA
    • TABLE 215: Argentina Recent Past, Current & Future Analysis for Implantable Pumps by Product Type - Patient-Controlled Analgesia Pump, Enteral Pump, Insulin Pump, Elastomeric Pump and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 216: Argentina Historic Review for Implantable Pumps by Product Type - Patient-Controlled Analgesia Pump, Enteral Pump, Insulin Pump, Elastomeric Pump and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 217: Argentina 16-Year Perspective for Implantable Pumps by Product Type - Percentage Breakdown of Value Sales for Patient-Controlled Analgesia Pump, Enteral Pump, Insulin Pump, Elastomeric Pump and Other Product Types for the Years 2014, 2025 & 2030
    • TABLE 218: Argentina Recent Past, Current & Future Analysis for Implantable Pumps by Application - Other Applications, Oncology Application, Pediatrics / Neonatology Application, Gastroenterology Application and Hematology Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 219: Argentina Historic Review for Implantable Pumps by Application - Other Applications, Oncology Application, Pediatrics / Neonatology Application, Gastroenterology Application and Hematology Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 220: Argentina 16-Year Perspective for Implantable Pumps by Application - Percentage Breakdown of Value Sales for Other Applications, Oncology Application, Pediatrics / Neonatology Application, Gastroenterology Application and Hematology Application for the Years 2014, 2025 & 2030
    • TABLE 221: Argentina Recent Past, Current & Future Analysis for Implantable Pumps by End-Use - Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Home Healthcare End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 222: Argentina Historic Review for Implantable Pumps by End-Use - Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Home Healthcare End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 223: Argentina 16-Year Perspective for Implantable Pumps by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Home Healthcare End-Use for the Years 2014, 2025 & 2030
  • BRAZIL
    • TABLE 224: Brazil Recent Past, Current & Future Analysis for Implantable Pumps by Product Type - Patient-Controlled Analgesia Pump, Enteral Pump, Insulin Pump, Elastomeric Pump and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 225: Brazil Historic Review for Implantable Pumps by Product Type - Patient-Controlled Analgesia Pump, Enteral Pump, Insulin Pump, Elastomeric Pump and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 226: Brazil 16-Year Perspective for Implantable Pumps by Product Type - Percentage Breakdown of Value Sales for Patient-Controlled Analgesia Pump, Enteral Pump, Insulin Pump, Elastomeric Pump and Other Product Types for the Years 2014, 2025 & 2030
    • TABLE 227: Brazil Recent Past, Current & Future Analysis for Implantable Pumps by Application - Other Applications, Oncology Application, Pediatrics / Neonatology Application, Gastroenterology Application and Hematology Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 228: Brazil Historic Review for Implantable Pumps by Application - Other Applications, Oncology Application, Pediatrics / Neonatology Application, Gastroenterology Application and Hematology Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 229: Brazil 16-Year Perspective for Implantable Pumps by Application - Percentage Breakdown of Value Sales for Other Applications, Oncology Application, Pediatrics / Neonatology Application, Gastroenterology Application and Hematology Application for the Years 2014, 2025 & 2030
    • TABLE 230: Brazil Recent Past, Current & Future Analysis for Implantable Pumps by End-Use - Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Home Healthcare End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 231: Brazil Historic Review for Implantable Pumps by End-Use - Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Home Healthcare End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 232: Brazil 16-Year Perspective for Implantable Pumps by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Home Healthcare End-Use for the Years 2014, 2025 & 2030
  • MEXICO
    • TABLE 233: Mexico Recent Past, Current & Future Analysis for Implantable Pumps by Product Type - Patient-Controlled Analgesia Pump, Enteral Pump, Insulin Pump, Elastomeric Pump and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 234: Mexico Historic Review for Implantable Pumps by Product Type - Patient-Controlled Analgesia Pump, Enteral Pump, Insulin Pump, Elastomeric Pump and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 235: Mexico 16-Year Perspective for Implantable Pumps by Product Type - Percentage Breakdown of Value Sales for Patient-Controlled Analgesia Pump, Enteral Pump, Insulin Pump, Elastomeric Pump and Other Product Types for the Years 2014, 2025 & 2030
    • TABLE 236: Mexico Recent Past, Current & Future Analysis for Implantable Pumps by Application - Other Applications, Oncology Application, Pediatrics / Neonatology Application, Gastroenterology Application and Hematology Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 237: Mexico Historic Review for Implantable Pumps by Application - Other Applications, Oncology Application, Pediatrics / Neonatology Application, Gastroenterology Application and Hematology Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 238: Mexico 16-Year Perspective for Implantable Pumps by Application - Percentage Breakdown of Value Sales for Other Applications, Oncology Application, Pediatrics / Neonatology Application, Gastroenterology Application and Hematology Application for the Years 2014, 2025 & 2030
    • TABLE 239: Mexico Recent Past, Current & Future Analysis for Implantable Pumps by End-Use - Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Home Healthcare End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 240: Mexico Historic Review for Implantable Pumps by End-Use - Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Home Healthcare End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 241: Mexico 16-Year Perspective for Implantable Pumps by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Home Healthcare End-Use for the Years 2014, 2025 & 2030
  • REST OF LATIN AMERICA
    • TABLE 242: Rest of Latin America Recent Past, Current & Future Analysis for Implantable Pumps by Product Type - Patient-Controlled Analgesia Pump, Enteral Pump, Insulin Pump, Elastomeric Pump and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 243: Rest of Latin America Historic Review for Implantable Pumps by Product Type - Patient-Controlled Analgesia Pump, Enteral Pump, Insulin Pump, Elastomeric Pump and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 244: Rest of Latin America 16-Year Perspective for Implantable Pumps by Product Type - Percentage Breakdown of Value Sales for Patient-Controlled Analgesia Pump, Enteral Pump, Insulin Pump, Elastomeric Pump and Other Product Types for the Years 2014, 2025 & 2030
    • TABLE 245: Rest of Latin America Recent Past, Current & Future Analysis for Implantable Pumps by Application - Other Applications, Oncology Application, Pediatrics / Neonatology Application, Gastroenterology Application and Hematology Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 246: Rest of Latin America Historic Review for Implantable Pumps by Application - Other Applications, Oncology Application, Pediatrics / Neonatology Application, Gastroenterology Application and Hematology Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 247: Rest of Latin America 16-Year Perspective for Implantable Pumps by Application - Percentage Breakdown of Value Sales for Other Applications, Oncology Application, Pediatrics / Neonatology Application, Gastroenterology Application and Hematology Application for the Years 2014, 2025 & 2030
    • TABLE 248: Rest of Latin America Recent Past, Current & Future Analysis for Implantable Pumps by End-Use - Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Home Healthcare End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 249: Rest of Latin America Historic Review for Implantable Pumps by End-Use - Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Home Healthcare End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 250: Rest of Latin America 16-Year Perspective for Implantable Pumps by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Home Healthcare End-Use for the Years 2014, 2025 & 2030
  • MIDDLE EAST
    • Implantable Pumps Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
    • TABLE 251: Middle East Recent Past, Current & Future Analysis for Implantable Pumps by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 252: Middle East Historic Review for Implantable Pumps by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 253: Middle East 16-Year Perspective for Implantable Pumps by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2014, 2025 & 2030
    • TABLE 254: Middle East Recent Past, Current & Future Analysis for Implantable Pumps by Product Type - Patient-Controlled Analgesia Pump, Enteral Pump, Insulin Pump, Elastomeric Pump and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 255: Middle East Historic Review for Implantable Pumps by Product Type - Patient-Controlled Analgesia Pump, Enteral Pump, Insulin Pump, Elastomeric Pump and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 256: Middle East 16-Year Perspective for Implantable Pumps by Product Type - Percentage Breakdown of Value Sales for Patient-Controlled Analgesia Pump, Enteral Pump, Insulin Pump, Elastomeric Pump and Other Product Types for the Years 2014, 2025 & 2030
    • TABLE 257: Middle East Recent Past, Current & Future Analysis for Implantable Pumps by Application - Other Applications, Oncology Application, Pediatrics / Neonatology Application, Gastroenterology Application and Hematology Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 258: Middle East Historic Review for Implantable Pumps by Application - Other Applications, Oncology Application, Pediatrics / Neonatology Application, Gastroenterology Application and Hematology Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 259: Middle East 16-Year Perspective for Implantable Pumps by Application - Percentage Breakdown of Value Sales for Other Applications, Oncology Application, Pediatrics / Neonatology Application, Gastroenterology Application and Hematology Application for the Years 2014, 2025 & 2030
    • TABLE 260: Middle East Recent Past, Current & Future Analysis for Implantable Pumps by End-Use - Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Home Healthcare End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 261: Middle East Historic Review for Implantable Pumps by End-Use - Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Home Healthcare End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 262: Middle East 16-Year Perspective for Implantable Pumps by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Home Healthcare End-Use for the Years 2014, 2025 & 2030
  • IRAN
    • TABLE 263: Iran Recent Past, Current & Future Analysis for Implantable Pumps by Product Type - Patient-Controlled Analgesia Pump, Enteral Pump, Insulin Pump, Elastomeric Pump and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 264: Iran Historic Review for Implantable Pumps by Product Type - Patient-Controlled Analgesia Pump, Enteral Pump, Insulin Pump, Elastomeric Pump and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 265: Iran 16-Year Perspective for Implantable Pumps by Product Type - Percentage Breakdown of Value Sales for Patient-Controlled Analgesia Pump, Enteral Pump, Insulin Pump, Elastomeric Pump and Other Product Types for the Years 2014, 2025 & 2030
    • TABLE 266: Iran Recent Past, Current & Future Analysis for Implantable Pumps by Application - Other Applications, Oncology Application, Pediatrics / Neonatology Application, Gastroenterology Application and Hematology Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 267: Iran Historic Review for Implantable Pumps by Application - Other Applications, Oncology Application, Pediatrics / Neonatology Application, Gastroenterology Application and Hematology Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 268: Iran 16-Year Perspective for Implantable Pumps by Application - Percentage Breakdown of Value Sales for Other Applications, Oncology Application, Pediatrics / Neonatology Application, Gastroenterology Application and Hematology Application for the Years 2014, 2025 & 2030
    • TABLE 269: Iran Recent Past, Current & Future Analysis for Implantable Pumps by End-Use - Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Home Healthcare End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 270: Iran Historic Review for Implantable Pumps by End-Use - Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Home Healthcare End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 271: Iran 16-Year Perspective for Implantable Pumps by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Home Healthcare End-Use for the Years 2014, 2025 & 2030
  • ISRAEL
    • TABLE 272: Israel Recent Past, Current & Future Analysis for Implantable Pumps by Product Type - Patient-Controlled Analgesia Pump, Enteral Pump, Insulin Pump, Elastomeric Pump and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 273: Israel Historic Review for Implantable Pumps by Product Type - Patient-Controlled Analgesia Pump, Enteral Pump, Insulin Pump, Elastomeric Pump and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 274: Israel 16-Year Perspective for Implantable Pumps by Product Type - Percentage Breakdown of Value Sales for Patient-Controlled Analgesia Pump, Enteral Pump, Insulin Pump, Elastomeric Pump and Other Product Types for the Years 2014, 2025 & 2030
    • TABLE 275: Israel Recent Past, Current & Future Analysis for Implantable Pumps by Application - Other Applications, Oncology Application, Pediatrics / Neonatology Application, Gastroenterology Application and Hematology Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 276: Israel Historic Review for Implantable Pumps by Application - Other Applications, Oncology Application, Pediatrics / Neonatology Application, Gastroenterology Application and Hematology Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 277: Israel 16-Year Perspective for Implantable Pumps by Application - Percentage Breakdown of Value Sales for Other Applications, Oncology Application, Pediatrics / Neonatology Application, Gastroenterology Application and Hematology Application for the Years 2014, 2025 & 2030
    • TABLE 278: Israel Recent Past, Current & Future Analysis for Implantable Pumps by End-Use - Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Home Healthcare End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 279: Israel Historic Review for Implantable Pumps by End-Use - Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Home Healthcare End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 280: Israel 16-Year Perspective for Implantable Pumps by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Home Healthcare End-Use for the Years 2014, 2025 & 2030
  • SAUDI ARABIA
    • TABLE 281: Saudi Arabia Recent Past, Current & Future Analysis for Implantable Pumps by Product Type - Patient-Controlled Analgesia Pump, Enteral Pump, Insulin Pump, Elastomeric Pump and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 282: Saudi Arabia Historic Review for Implantable Pumps by Product Type - Patient-Controlled Analgesia Pump, Enteral Pump, Insulin Pump, Elastomeric Pump and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 283: Saudi Arabia 16-Year Perspective for Implantable Pumps by Product Type - Percentage Breakdown of Value Sales for Patient-Controlled Analgesia Pump, Enteral Pump, Insulin Pump, Elastomeric Pump and Other Product Types for the Years 2014, 2025 & 2030
    • TABLE 284: Saudi Arabia Recent Past, Current & Future Analysis for Implantable Pumps by Application - Other Applications, Oncology Application, Pediatrics / Neonatology Application, Gastroenterology Application and Hematology Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 285: Saudi Arabia Historic Review for Implantable Pumps by Application - Other Applications, Oncology Application, Pediatrics / Neonatology Application, Gastroenterology Application and Hematology Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 286: Saudi Arabia 16-Year Perspective for Implantable Pumps by Application - Percentage Breakdown of Value Sales for Other Applications, Oncology Application, Pediatrics / Neonatology Application, Gastroenterology Application and Hematology Application for the Years 2014, 2025 & 2030
    • TABLE 287: Saudi Arabia Recent Past, Current & Future Analysis for Implantable Pumps by End-Use - Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Home Healthcare End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 288: Saudi Arabia Historic Review for Implantable Pumps by End-Use - Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Home Healthcare End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 289: Saudi Arabia 16-Year Perspective for Implantable Pumps by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Home Healthcare End-Use for the Years 2014, 2025 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 290: UAE Recent Past, Current & Future Analysis for Implantable Pumps by Product Type - Patient-Controlled Analgesia Pump, Enteral Pump, Insulin Pump, Elastomeric Pump and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 291: UAE Historic Review for Implantable Pumps by Product Type - Patient-Controlled Analgesia Pump, Enteral Pump, Insulin Pump, Elastomeric Pump and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 292: UAE 16-Year Perspective for Implantable Pumps by Product Type - Percentage Breakdown of Value Sales for Patient-Controlled Analgesia Pump, Enteral Pump, Insulin Pump, Elastomeric Pump and Other Product Types for the Years 2014, 2025 & 2030
    • TABLE 293: UAE Recent Past, Current & Future Analysis for Implantable Pumps by Application - Other Applications, Oncology Application, Pediatrics / Neonatology Application, Gastroenterology Application and Hematology Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 294: UAE Historic Review for Implantable Pumps by Application - Other Applications, Oncology Application, Pediatrics / Neonatology Application, Gastroenterology Application and Hematology Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 295: UAE 16-Year Perspective for Implantable Pumps by Application - Percentage Breakdown of Value Sales for Other Applications, Oncology Application, Pediatrics / Neonatology Application, Gastroenterology Application and Hematology Application for the Years 2014, 2025 & 2030
    • TABLE 296: UAE Recent Past, Current & Future Analysis for Implantable Pumps by End-Use - Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Home Healthcare End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 297: UAE Historic Review for Implantable Pumps by End-Use - Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Home Healthcare End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 298: UAE 16-Year Perspective for Implantable Pumps by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Home Healthcare End-Use for the Years 2014, 2025 & 2030
  • REST OF MIDDLE EAST
    • TABLE 299: Rest of Middle East Recent Past, Current & Future Analysis for Implantable Pumps by Product Type - Patient-Controlled Analgesia Pump, Enteral Pump, Insulin Pump, Elastomeric Pump and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 300: Rest of Middle East Historic Review for Implantable Pumps by Product Type - Patient-Controlled Analgesia Pump, Enteral Pump, Insulin Pump, Elastomeric Pump and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 301: Rest of Middle East 16-Year Perspective for Implantable Pumps by Product Type - Percentage Breakdown of Value Sales for Patient-Controlled Analgesia Pump, Enteral Pump, Insulin Pump, Elastomeric Pump and Other Product Types for the Years 2014, 2025 & 2030
    • TABLE 302: Rest of Middle East Recent Past, Current & Future Analysis for Implantable Pumps by Application - Other Applications, Oncology Application, Pediatrics / Neonatology Application, Gastroenterology Application and Hematology Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 303: Rest of Middle East Historic Review for Implantable Pumps by Application - Other Applications, Oncology Application, Pediatrics / Neonatology Application, Gastroenterology Application and Hematology Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 304: Rest of Middle East 16-Year Perspective for Implantable Pumps by Application - Percentage Breakdown of Value Sales for Other Applications, Oncology Application, Pediatrics / Neonatology Application, Gastroenterology Application and Hematology Application for the Years 2014, 2025 & 2030
    • TABLE 305: Rest of Middle East Recent Past, Current & Future Analysis for Implantable Pumps by End-Use - Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Home Healthcare End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 306: Rest of Middle East Historic Review for Implantable Pumps by End-Use - Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Home Healthcare End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 307: Rest of Middle East 16-Year Perspective for Implantable Pumps by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Home Healthcare End-Use for the Years 2014, 2025 & 2030
  • AFRICA
    • Implantable Pumps Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
    • TABLE 308: Africa Recent Past, Current & Future Analysis for Implantable Pumps by Product Type - Patient-Controlled Analgesia Pump, Enteral Pump, Insulin Pump, Elastomeric Pump and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 309: Africa Historic Review for Implantable Pumps by Product Type - Patient-Controlled Analgesia Pump, Enteral Pump, Insulin Pump, Elastomeric Pump and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 310: Africa 16-Year Perspective for Implantable Pumps by Product Type - Percentage Breakdown of Value Sales for Patient-Controlled Analgesia Pump, Enteral Pump, Insulin Pump, Elastomeric Pump and Other Product Types for the Years 2014, 2025 & 2030
    • TABLE 311: Africa Recent Past, Current & Future Analysis for Implantable Pumps by Application - Other Applications, Oncology Application, Pediatrics / Neonatology Application, Gastroenterology Application and Hematology Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 312: Africa Historic Review for Implantable Pumps by Application - Other Applications, Oncology Application, Pediatrics / Neonatology Application, Gastroenterology Application and Hematology Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 313: Africa 16-Year Perspective for Implantable Pumps by Application - Percentage Breakdown of Value Sales for Other Applications, Oncology Application, Pediatrics / Neonatology Application, Gastroenterology Application and Hematology Application for the Years 2014, 2025 & 2030
    • TABLE 314: Africa Recent Past, Current & Future Analysis for Implantable Pumps by End-Use - Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Home Healthcare End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 315: Africa Historic Review for Implantable Pumps by End-Use - Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Home Healthcare End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 316: Africa 16-Year Perspective for Implantable Pumps by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Home Healthcare End-Use for the Years 2014, 2025 & 2030

IV. COMPETITION

샘플 요청 목록
0 건의 상품을 선택 중
목록 보기
전체삭제